IsoRay, Inc. (DE) (ISR) earnings
Quarterly and annual ISR reports and results, each read against the price at its own news timestamp. Back to the ISR overview →
1 measured ISR earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Perspective Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | — |
Keep exploring
More ISR: analyst actions → · SEC filings → · ISR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | 725 | 0.00% | 47% |
| RETROPHIN INC (RTRX) | 723 | +0.06% | 52% |
| Pfizer, Inc. (PFE) | 721 | -0.04% | 46% |
| ESSA Pharma Inc. (EPIX) | 718 | 0.00% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.